Volume 53, Issue 3, Pages (March 2008)

Slides:



Advertisements
Similar presentations
Volume 62, Issue 4, Pages (October 2012)
Advertisements

Early Detection of Prostate Cancer in 2007
The PSA Era is not Over for Prostate Cancer
Volume 50, Issue 1, Pages (July 2006)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 58, Issue 4, Pages (October 2010)
Testosterone Therapy in Men With Prostate Cancer
Volume 68, Issue 6, Pages e129-e131 (December 2015)
Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer  Marisa Warmuth,
Volume 74, Issue 4, Pages (October 2018)
Volume 53, Issue 4, Pages (April 2008)
Prostate Cancer: Highlights from 2006
Control of Prostate Cancer by Transrectal HIFU in 227 Patients
Volume 51, Issue 4, Pages (April 2007)
Volume 65, Issue 5, Pages (May 2014)
Prostate Cancer Epidemic in Sight?
Volume 52, Issue 4, Pages (October 2007)
Failure to Achieve Castration Levels in Patients Using Leuprolide Acetate in Locally Advanced Prostate Cancer  Olav Erich Yri, Trine Bjoro, Sophie D.
Volume 63, Issue 4, Pages e53-e56 (April 2013)
Volume 199, Issue 4, Pages (April 2018)
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 54, Issue 4, Pages (October 2008)
Volume 71, Issue 1, Pages 1-3 (January 2017)
Volume 53, Issue 4, Pages (April 2008)
Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?
Volume 70, Issue 3, Pages (September 2016)
Prostate Cancer Detection: A View of the Future
Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance  Adam B. Weiner, Ruth Etzioni, Scott E. Eggener 
Volume 54, Issue 5, Pages (November 2008)
Volume 67, Issue 3, Pages (March 2015)
Volume 56, Issue 2, Pages (August 2009)
Volume 65, Issue 4, Pages (April 2014)
Volume 64, Issue 6, Pages (December 2013)
Prostate Cancer Epidemic in Sight?
The PSA Era is not Over for Prostate Cancer
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 58, Issue 4, Pages (October 2010)
Volume 53, Issue 6, Pages (June 2008)
Volume 53, Issue 4, Pages (April 2008)
Volume 63, Issue 3, Pages (March 2013)
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Volume 65, Issue 6, Pages (June 2014)
Tillmann Loch, Pat Fox Fulgham  European Urology 
Volume 53, Issue 1, Pages (January 2008)
Volume 68, Issue 4, Pages (October 2015)
Is It Necessary to Detect All Prostate Cancers in Men with Serum PSA Levels
Volume 50, Issue 5, Pages (November 2006)
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 55, Issue 3, Pages (March 2009)
Prostate Specific Antigen Doubling Time as Auxiliary End Point in Hormone Refractory Prostatic Carcinoma  Hans-Peter Schmid, Rudolf Morant, Jürg Bernhard,
Testicular Cancer Variations in Time and Space in Europe
Volume 53, Issue 1, Pages (January 2008)
The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.
Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?
Challenges and Opportunities in Hormone-Resistant Prostate Cancer
European Urology is “Your” Journal
Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg 
Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders
Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.
Volume 55, Issue 6, Pages (June 2009)
Economic Burden of Bladder Cancer Across the European Union
Pulmonary Resection for Lung Cancer in Octogenarians
Highlighting Unmet Needs: Real Patients, Difficult Choices
Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson 
Volume 53, Issue 2, Pages (February 2008)
Volume 52, Issue 1, Pages (July 2007)
Oncoforum Urology: Prostate Cancer 2008 at a Glance
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
Volume 54, Issue 1, Pages (July 2008)
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Volume 53, Issue 3, Pages 547-553 (March 2008) PSA Nadir Is a Significant Predictor of Treatment Failure after High-Intensity Focussed Ultrasound (HIFU) Treatment of Localised Prostate Cancer  Roman Ganzer, Sebastian Rogenhofer, Bernhard Walter, Jens-Claudio Lunz, Martin Schostak, Wolf F. Wieland, Andreas Blana  European Urology  Volume 53, Issue 3, Pages 547-553 (March 2008) DOI: 10.1016/j.eururo.2007.07.010 Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 1 Actuarial disease–free survival rates for three prostate-specific antigen nadir groups defined by the new American Society of Therapeutic Radiology and Oncology criteria. European Urology 2008 53, 547-553DOI: (10.1016/j.eururo.2007.07.010) Copyright © 2007 European Association of Urology Terms and Conditions